Literature DB >> 3262615

Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.

J Pieters1, G Willems, H C Hemker, T Lindhout.   

Abstract

We investigated the kinetics of the inhibitory action of antithrombin III and antithrombin III plus heparin during the activation of factor X by factor IXa. Generation and inactivation curves were fitted to a three-parameter two-exponentional model to determine the pseudo first-order rate constants of inhibition of factor IXa and factor Xa by antithrombin III/heparin. In the absence of heparin, the second-order rate constant of inhibition of factor Xa generated by factor IXa was 2.5-fold lower than the rate constant of inhibition of exogenous factor Xa. It appeared that phospholipid-bound factor X protected factor Xa from inactivation by antithrombin III. It is, as yet, unclear whether an active site or a nonactive site interaction between factor Xa and factor X at the phospholipid surface is involved. The inactivation of factor IXa by antithrombin III was found to be very slow and was not affected by phospholipid, calcium, and/or factor X. With unfractionated heparin above 40 ng/ml and antithrombin III at 200 nM, the apparent second-order rate constant of inhibition of exogenous and generated factor Xa were the same. Thus, in this case phospholipid-bound factor X did not protect factor Xa from inhibition. In the presence of synthetic pentasaccharide heparin, however, phospholipid-bound factor X reduced the rate constant about 5-fold. Pentasaccharide had no effect on the factor IXa/antithrombin III reaction. Unfractionated heparin (1 micrograms/ml) stimulated the antithrombin III-dependent inhibition of factor IXa during factor X activation 400-fold. In the absence of reaction components this stimulated was 65-fold. We established that calcium stimulated the heparin-dependent inhibition of factor IXa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262615

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

Review 1.  Fondaparinux sodium.

Authors:  Susan J Keam; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Thrombin activity propagates in space during blood coagulation as an excitation wave.

Authors:  N M Dashkevich; M V Ovanesov; A N Balandina; S S Karamzin; P I Shestakov; N P Soshitova; A A Tokarev; M A Panteleev; F I Ataullakhanov
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

Review 3.  Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery.

Authors:  Neil A Reynolds; Caroline M Perry; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Gut Serpinome: Emerging Evidence in IBD.

Authors:  Héla Mkaouar; Vincent Mariaule; Soufien Rhimi; Juan Hernandez; Aicha Kriaa; Amin Jablaoui; Nizar Akermi; Emmanuelle Maguin; Adam Lesner; Brice Korkmaz; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

5.  Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.

Authors:  Garabet G Toby; Tongyao Liu; Yang Buyue; Xin Zhang; Alan J Bitonti; Glenn F Pierce; Jurg M Sommer; Haiyan Jiang; Robert T Peters
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.